BackWuhan Hiteck Biological Pharma ,Ltd Overview

Wuhan Hiteck Biological Pharma ,Ltd Receivables

Wuhan Hiteck Biological Pharma ,Ltd's receivables is $280M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$282.37M
↓ 9.87% YoYΔ $-30.93M vs prior year quarter

Peer trimmed avg / median

Loading

Wuhan Hiteck Biological Pharma ,Ltd Receivables History

Loading

Wuhan Hiteck Biological Pharma ,Ltd vs. peers: Receivables Comparison

Loading

Wuhan Hiteck Biological Pharma ,Ltd Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Wuhan Hiteck Biological Pharma ,Ltd (300683.SZ) FAQ

The latest receivables for 300683.SZ is $280M as of September 2026. That compares with $310M in the prior-year period — down 9.9% year over year. Investors often review this figure alongside Wuhan Hiteck Biological Pharma ,Ltd's historical trend and sector peers before judging valuation or financial health.

Over the past year, 300683.SZ's receivables moved from $310M to $280M — a 9.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Wuhan Hiteck Biological Pharma ,Ltd's operating scale or balance-sheet position.

A receivables figure of $280M for 300683.SZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 300683.SZ's receivables ($280M), review year-over-year change from $310M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.